Asa Abeliovich - Net Worth and Insider Trading

Asa Abeliovich Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Asa Abeliovich owns 1 companies in total, including Prevail Therapeutics Inc (PRVL) .

Click here to see the complete history of Asa Abeliovich’s form 4 insider trades.

Insider Ownership Summary of Asa Abeliovich

Ticker Comapny Transaction Date Type of Owner
PRVL Prevail Therapeutics Inc 2020-02-19 director & 10 percent owner & President & CEO

Asa Abeliovich Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Asa Abeliovich Ownership Network

Ownership Network List of Asa Abeliovich

No Data

Ownership Network Relation of Asa Abeliovich

Insider Network Chart

Asa Abeliovich Owned Company Details

What does Prevail Therapeutics Inc do?

Who are the key executives at Prevail Therapeutics Inc?

Asa Abeliovich is the director & 10 percent owner & President & CEO of Prevail Therapeutics Inc. Other key executives at Prevail Therapeutics Inc include director & 10 percent owner Carl L Gordon , director & 10 percent owner Peter A. Thompson , and General Counsel Kira M. Schwartz .

Prevail Therapeutics Inc (PRVL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Prevail Therapeutics Inc (PRVL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Prevail Therapeutics Inc (PRVL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Prevail Therapeutics Inc (PRVL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Prevail Therapeutics Inc Insider Transactions

No Available Data

Asa Abeliovich Mailing Address

Above is the net worth, insider trading, and ownership report for Asa Abeliovich. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Asa Abeliovich's mailing address is: Suite 940 New York Ny 10016.